Group 1 - The core point of the news is that Jiahe Meikang's stock price has dropped by 5.07%, currently trading at 23.05 yuan per share, with a total market capitalization of 3.171 billion yuan [1] - Jiahe Meikang (Beijing) Technology Co., Ltd. was established on March 3, 2006, and went public on December 14, 2021. The company specializes in the research and industrialization of medical information software [1] - The revenue composition of Jiahe Meikang includes: software development and technical services (42.39%), self-developed software sales (37.64%), purchased software and hardware sales (19.86%), and other service sales (0.11%) [1] Group 2 - From the perspective of fund holdings, one fund under Taixin Fund has Jiahe Meikang as a major holding. The Taixin Internet + Theme Mixed A Fund (001978) held 6,947 shares in the third quarter, accounting for 4.93% of the fund's net value, making it the largest holding [2] - The Taixin Internet + Theme Mixed A Fund (001978) was established on June 8, 2016, with a latest scale of 4.2898 million. It has experienced a loss of 6.04% this year, ranking 8,110 out of 8,159 in its category [2] - The fund manager of Taixin Internet + Theme Mixed A is Chen Ying, who has been in the position for 3 years and 348 days, with a total asset scale of 540 million yuan. The best fund return during the tenure is 15.67%, while the worst is -14.68% [3]

Group 1 - The core viewpoint of the news is that 嘉和美康 (Jiahe Meikang) experienced a decline in stock price and significant changes in financing and shareholder structure, indicating potential challenges in its financial performance and market position [1][2]. Group 2 - On December 24, 嘉和美康's stock fell by 2.41%, with a trading volume of 119 million yuan. The financing data showed a net financing outflow of 1.46 million yuan, with a total financing balance of 186 million yuan, accounting for 5.64% of the circulating market value [1]. - The company’s financing balance is above the 70th percentile of the past year, indicating a relatively high level of financing activity [1]. - 嘉和美康's short selling data on December 24 showed no shares were sold or repaid, with a short selling balance of 13,500 shares, which is above the 90th percentile of the past year [1]. - As of November 10, 嘉和美康 had 8,866 shareholders, an increase of 16.78%, while the average number of circulating shares per shareholder decreased by 14.37% [2]. - For the period from January to September 2025, 嘉和美康 reported a revenue of 330 million yuan, a year-on-year decrease of 30.67%, and a net profit attributable to shareholders of -174 million yuan, a significant decline of 320.68% [2]. - Among the top ten circulating shareholders, 长城消费增值混合A (Changcheng Consumption Value Mixed A) held 2.00 million shares, a decrease of 410,000 shares compared to the previous period [2].

Group 1 - The core viewpoint of the news is that 嘉和美康 experienced a significant decline in stock price and financial performance, indicating potential challenges for the company [1][2]. Group 2 - On December 23, 嘉和美康's stock price dropped by 5.15%, with a trading volume of 145 million yuan. The financing data showed a net financing outflow of 770,700 yuan for the day [1]. - As of December 23, 嘉和美康's total margin trading balance was 187 million yuan, accounting for 5.55% of its market capitalization, which is above the 80th percentile of the past year [1]. - The company had no short selling activity on December 23, with a short selling balance of 331,000 yuan, also above the 90th percentile of the past year [1]. - 嘉和美康's main business includes medical information software development and commercialization, with revenue composition being 42.39% from software development and technical services, 37.64% from self-developed software sales, and 19.86% from purchased software and hardware sales [1]. Group 3 - As of November 10, 嘉和美康 had 8,866 shareholders, an increase of 16.78%, while the average circulating shares per person decreased by 14.37% [2]. - For the period from January to September 2025, 嘉和美康 reported a revenue of 330 million yuan, a year-on-year decrease of 30.67%, and a net profit attributable to shareholders of -174 million yuan, a year-on-year decrease of 320.68% [2]. - Among the top ten circulating shareholders as of September 30, 2025, 长城消费增值混合A held 2.001 million shares, a decrease of 410,000 shares compared to the previous period [2].

Group 1 - The core point of the news is that Jiahe Meikang's stock price dropped by 5.03% to 24.52 yuan per share, with a trading volume of 1.23 billion yuan and a turnover rate of 3.56%, resulting in a total market capitalization of 3.374 billion yuan [1] - Jiahe Meikang (Beijing) Technology Co., Ltd. was established on March 3, 2006, and went public on December 14, 2021. The company specializes in the research and industrialization of medical information software [1] - The revenue composition of Jiahe Meikang includes software development and technical services at 42.39%, self-developed software sales at 37.64%, purchased software and hardware sales at 19.86%, and other service sales at 0.11% [1] Group 2 - From the perspective of major fund holdings, the Guoxin Guozheng Fund has one fund heavily invested in Jiahe Meikang. The Guoxin Guozheng Xinli A (001797) held 9,000 shares in the third quarter, unchanged from the previous period, accounting for 1.26% of the fund's net value, ranking as the eighth largest holding [2] - The Guoxin Guozheng Xinli A (001797) was established on September 2, 2015, with a latest scale of 20.6671 million. Year-to-date returns are 11.34%, ranking 5,539 out of 8,088 in its category; the one-year return is 9.78%, ranking 5,659 out of 8,057; and since inception, it has incurred a loss of 13.6% [2]

证券时报·数据宝统计显示，上榜的前五大买卖营业部合计成交9045.52万元， 其中，买入成交额为 5501.84万元，卖出成交额为3543.68万元，合计净买入1958.17万元。具体来看，今日上榜营业部中，第 一大买入营业部为高盛(中国)证券有限责任公司上海浦东新区世纪大道证券营业部，买入金额为1484.25 万元，其次是华鑫证券有限责任公司上海宛平南路证券营业部，买入金额1210.08万元。卖出营业部 中，有1家机构专用席位现身，即卖二，卖出金额分别为783.63万元，营业部合计卖出2760.05万元。买 卖金额相抵，机构专用席位今日净卖出该股783.63万元。 资金流向方面，该股今日全天主力资金净流入2981.42万元。（数据宝） 12月18日嘉和美康（688246）收盘价25.67元，收盘涨停，全天换手率8.52%，振幅21.20%，成交额2.81 亿元。科创板交易公开信息显示，当日该股因日收盘价涨幅达15%等上榜。 嘉和美康12月18日龙虎榜 | 买入营业部名称 | 买入金额(万元) | | --- | --- | | 高盛(中国)证券有限责任公司上海浦东新区世纪大道证券营业部 | 1484.25 ...

Market Overview - The A-share market experienced slight fluctuations today, with large-cap blue-chip stocks showing strength, as the Shanghai Composite Index and the Shanghai 50 Index slightly rose, while technology growth stocks faced adjustments, leading to small declines in the ChiNext Index, Sci-Tech 50, and North China 50. The market turnover reached 1.68 trillion yuan [1]. Index Performance - The Shenzhen Component Index closed at 13,053.97, down by 1.29% - The Shanghai Composite Index closed at 3,876.37, up by 0.16% - The ChiNext Index closed at 3,107.06, down by 2.17% - The Sci-Tech 50 Index closed at 1,305.97, down by 1.46% - The North China 50 Index closed at 1,431.71, down by 0.51% [2]. Sector Performance - Active sectors included pharmaceutical commerce, high-dividend stocks, elderly care concepts, and commercial aerospace, while sectors such as Hainan, consumer electronics, glass fiber, and power grid equipment saw the largest declines [2]. - Defense and military industry attracted over 9.5 billion yuan in net inflows, while banking received over 5.5 billion yuan. Other sectors like automotive and biopharmaceuticals also saw significant inflows exceeding 4 billion yuan [3]. Investment Insights - Huazhang Securities noted that historically, years of significant gains see increased volatility in January of the following year, suggesting a potential adjustment phase ahead. Investors are advised to remain patient and await clearer signals for upward trends. The AI industry is highlighted as a stable long-term investment focus [3]. - Guotai Junan emphasized that the spring market typically starts between December and April, with potential early initiation if prior market adjustments and favorable policy expectations align. Current market conditions present a crucial window for positioning in the spring rally [3]. High Dividend Stocks - High-dividend stocks saw a strong performance in the afternoon, with all bank stocks rising. Notable gainers included Shanghai Bank and Chongqing Rural Commercial Bank [4]. - The demand for stable cash flows from long-term funds like insurance and pension funds has increased significantly in a low-interest-rate environment. Insurance companies are projected to increase equity allocations by over 410 billion yuan in the first three quarters of 2025, with high-dividend assets comprising over half of the new positions [4]. Elderly Care Sector - The elderly care concept stocks were notably active, with companies like Jiayou Meikang and Waineng Health hitting their daily limit up of 20% [4]. - The National Health Commission has issued a plan to enhance elderly care services, aiming for a more comprehensive system by 2027 [5]. Silver Economy - The silver economy market in China is projected to reach 8.3 trillion yuan by 2024 and exceed 20 trillion yuan by 2030, with the consumption potential of the elderly population expected to grow to 106 trillion yuan by 2050, positioning China as a leader in the global silver economy market [6]. - CITIC Securities forecasts that the number of new pension recipients will increase by approximately 5.5 to 6 million annually over the next 2-3 years, which will be a significant driver for the silver economy and domestic demand expansion [6].

Market Overview - A total of 61 stocks hit the daily limit up, while 19 stocks faced limit down, resulting in a sealing rate of 76% [1] - The Shanghai Composite Index rose by 0.16%, while the Shenzhen Component Index and the ChiNext Index fell by 1.29% and 2.17% respectively [1] - The total trading volume in the Shanghai and Shenzhen markets was 1.66 trillion, a decrease of 155.7 billion from the previous trading day [1] Stock Performance - Baida Group achieved a six-day limit up streak, while Shengtong Energy and Pinao recorded five and four consecutive limit ups respectively [1][3] - The number of stocks advancing was nearly 2900, with notable performances in the pharmaceutical, banking, and retail sectors [1] - The commercial aerospace concept saw a resurgence, with stocks like Shunhao and Xibu Materials hitting limit up after previous declines [3][5] Sector Analysis - The pharmaceutical commercial sector experienced significant growth due to increased orders amid a rise in respiratory diseases during the winter season [14][15] - The retail sector, particularly driven by the "reward economy," showed strong performance with stocks like Baida Group and Nanjing Shanglv achieving consecutive limit ups [6][12] - The AI healthcare sector remained active, with Ant Group's AI health app "Antifortune" gaining popularity, leading to limit ups for companies like Meian Health and Huaren Health [7][19] Investment Themes - The commercial aerospace sector is highlighted as a strategic emerging industry, with government support and recent rocket launches boosting investor sentiment [5] - The "reward economy" is emerging as a new consumption model among younger demographics, contributing to the growth of related sectors [6][12] - The IP economy is gaining traction, with government initiatives aimed at promoting new consumption models and financial support for innovative businesses [16] Future Outlook - The market is expected to continue experiencing volatility, with a focus on small-cap stocks and growth sectors as larger stocks face profit-taking [9] - The Shanghai Composite Index is attempting to recover above key moving averages, indicating potential for further upward movement if trading volume increases [9]

Core Viewpoint - The DRG/DIP concept sector experienced a significant increase of 3.87%, leading the market in terms of growth, with notable performances from stocks such as Jiahe Meikang and Saily Medical, which reached their daily limit up [1][2]. Group 1: Market Performance - The DRG/DIP concept sector had 19 stocks rising, with Jiahe Meikang hitting a 20% limit up, followed by Saily Medical at limit up, and other notable gainers including Weining Health, Dian Diagnostics, and Sichuang Medical, which rose by 11.11%, 8.65%, and 5.77% respectively [1]. - The sector saw a net inflow of 737 million yuan from main funds, with 17 stocks receiving net inflows, and 11 stocks exceeding 10 million yuan in net inflow [2]. - The top net inflow stock was Weining Health, attracting 347 million yuan, followed by Saily Medical, Rongke Technology, and Jiayuan Technology with net inflows of 166 million yuan, 83.78 million yuan, and 44.88 million yuan respectively [2]. Group 2: Fund Flow Ratios - Saily Medical, Digital Certification, and Weining Health had the highest net inflow ratios, with rates of 29.65%, 13.45%, and 12.89% respectively [3]. - The top stocks in the DRG/DIP concept based on net inflow include Weining Health with a daily increase of 11.11% and a turnover rate of 15.28%, and Saily Medical with a 9.99% increase and a turnover rate of 12.43% [3][4]. - Other notable stocks include Rongke Technology, Jiayuan Technology, and Jiahe Meikang, which also showed positive performance with increases of 0.90%, 3.27%, and 20.01% respectively [4].

消息面上，蚂蚁集团旗下AI健康应用"蚂蚁阿福"于12月15日发布后下载量猛增，16日冲上苹果应用榜总 榜第三位。据悉，"蚂蚁阿福"App月活用户规模已超1500万，每天回答用户500多万个健康提问。 据悉，AI医疗是通过机器学习、自然语言处理、计算机视觉等先进技术，对复杂的医疗数据进行深度 分析，辅助临床决策、优化诊疗流程、提升医疗效率的新型医疗体系，具备智能化、高效化、便捷化的 特征，应用前景广阔。根据甲子光年《2024年中国AI医疗产业研究报告》，2023年中国AI医疗行业规 模为973亿元，预计将在2028年达到1598亿元，2022—2028年间的年复合增长率为10.5%。细分市场 中，AI医学影像和AI制药增长较快。机构表示，随着生成式大模型等AI技术的不断发展，AI医疗将逐 步融入覆盖医疗产业各环节。 AI医疗概念18日盘中强势拉升，截至发稿，华人健康20%涨停，美年健康、塞力医疗亦涨停，嘉和美康 涨超9%。 ...

证券日报网讯 12月15日晚间，嘉和美康发布公告称，本次减持计划实施前，嘉和美康（北京）科技股 份有限公司（以下简称"嘉和美康"或"公司"）股东苏州赛富璞鑫医疗健康产业投资中心（有限合伙） （以下简称"赛富璞鑫"）持有公司股份2，672，492股，占公司股份总数的1.94%。公司于2025年9月11 日披露了《嘉和美康股东减持股份计划公告》，赛富璞鑫因股东流动性需求，拟通过集中竞价方式减持 其持有的公司股份不超过2，672，492股，即不超过公司总股本的1.94%。公司于近日收到公司股东赛 富璞鑫出具的《关于股份减持结果的告知函》，赛富璞鑫已于2025年9月16日至2025年12月12日期间通 过集中竞价方式累计减持所持有的公司股份2，672，492股，占公司当前股份总数的1.94%，本次减持 计划实施完毕。 （文章来源：证券日报） ...